The Effectiveness of Bottle-PEP in Chronic Obstructive Pulmonary Disease
NCT03900195 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2019-04-02
Summary
The effectiveness of Bottle PEP in patients with Chronic Obstructive Pulmonary Disease
Conditions
Interventions
- OTHER
-
BottlePEP
Positive expiratory device with a bottle
Sponsors & Collaborators
-
Marmara University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-21
- Primary Completion
- 2020-01-31
- Completion
- 2020-01-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)
NCT05114434 ·Status: UNKNOWN
-
Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients
NCT03359122 ·Status: COMPLETED
-
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758459 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)
NCT01646424 ·Status: COMPLETED
-
Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01054170 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease
NCT02366637 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
NCT01387230 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00929708 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
NCT00430300 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease
NCT03646864 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment and Exacerbation in COPD Subjects
NCT03375450 ·Status: COMPLETED
-
Efficacy Study of the Effect of Budesonide on Emphysema
NCT00232674 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of COPD Standardized Management on COPD Exacerbation
NCT04664491 ·Status: RECRUITING ·Phase: NA
-
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07288554 ·Status: RECRUITING ·Phase: PHASE1
-
An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.
NCT05492877 ·Status: COMPLETED ·Phase: PHASE2
-
The Asthma Bronchial Challenge Study
NCT03575663 ·Status: COMPLETED
-
A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease
NCT00219622 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug
NCT03235726 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT02294734 ·Status: COMPLETED ·Phase: PHASE2
-
A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects
NCT01754844 ·Status: COMPLETED ·Phase: PHASE1
-
Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation
NCT01332097 ·Status: COMPLETED ·Phase: PHASE2
-
A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01233232 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of DNK333 in Patients With COPD and Cough
NCT01287325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871
NCT02971293 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD
NCT00215436 ·Status: COMPLETED ·Phase: PHASE3